Compare Stocks: BIIB vs. OGN vs. NVO

Market Snapshot

Current market context for the selected companies.

BIIB

$224.32

Market Cap $32.90B

Sector Healthcare

Industry Drug Manufacturers - General

Data through 2026-09-03

OGN

$13.78

Market Cap $3.62B

Sector Healthcare

Industry Drug Manufacturers - General

Data through 2026-09-03

NVO

$47.45

Market Cap 206.77B

Sector Healthcare

Industry Drug Manufacturers - General

Data through 2026-09-03

Performance

Absolute returns and relative performance versus SPY.

Metric	BIIB	OGN	NVO
1 Month	+8.6%	+1.5%	+6.6%
1 Month vs SPY	+8.2%	+1.1%	+6.2%
3 Months	+14.2%	+2.8%	+8.4%
3 Months vs SPY	+12.1%	+0.7%	+6.4%
6 Months	+19.3%	+105.3%	+21.4%
6 Months vs SPY	+5.8%	+91.9%	+8.0%
1 Year	+58.4%	+40.1%	-16.4%
1 Year vs SPY	+38.4%	+20.1%	-36.4%
2 Years	+9.5%	-38.3%	-65.5%
2 Years vs SPY	-28.9%	-76.7%	-103.9%

Growth & Profitability

Operating growth, margins and capital efficiency.

Metric	BIIB	OGN	NVO
Revenue Growth	3.4%	-2.3%	2.1%
Earnings Growth	-84.8%	-28.3%	-20.6%
Gross Margin	78.3%	53.4%	82.0%
Operating Margin	25.1%	20.7%	42.5%
Net Margin	8.3%	3.4%	35.3%
Return on Equity	4.6%	24.0%	59.8%
Return on Assets	5.2%	5.7%	18.7%

Valuation

Common valuation multiples shown side by side.

Metric	BIIB	OGN	NVO
P / E	38.4	17.6	11.0
Forward P / E	13.5	3.8	13.7
P / S	3.2	0.6	0.6
P / B	1.7	3.6	5.8
EV / Sales	3.9	1.8	0.9
EV / EBIT	15.6	8.7	—
P / FCF	25.2	7.4	—
FCF Yield	4.0%	13.6%	—

Cash Flow & Balance Sheet

Cash generation and leverage context.

Metric	BIIB	OGN	NVO
Free Cash Flow	$1.27B	$490.75M	37.67B
Operating Cash Flow	$2.88B	$737.00M	131.88B
Debt / Equity	44.3%	850.2%	63.3%

Earnings Outlook

Upcoming earnings expectations when available.

Metric	BIIB	OGN	NVO
Next Earnings	2026-10-29	2026-11-09	2026-11-04
EPS Estimate	2.04	0.93	5.14
Revenue Estimate	2.64B	1.58B	72.91B
EPS Growth	-57.7%	-8.3%	+14.2%
Revenue Growth	+4.0%	-1.1%	-2.8%
Analyst Coverage	25	5	3